نتایج جستجو برای: hbsag

تعداد نتایج: 5038  

Journal: :The Journal of infectious diseases 2009
Ming-Lung Yu Chuan-Mo Lee Wan-Long Chuang Sheng-Nan Lu Chia-Yen Dai Jee-Fu Huang Zu-Yau Lin Tsung-Hui Hu Chien-Hung Chen Chao-Hung Hung Jin-Houng Wang Chi-Ling Chen Jia-Horng Kao Ming-Yang Lai Chen-Hua Liu Tung-Hung Su Shun-Sheng Wu Li-Ying Liao Hsing-Tao Kuo You-Chen Chao Shui-Yi Tung Sien-Sing Yang Pei-Jer Chen Chun-Jen Liu Ding-Shinn Chen

BACKGROUND With use of peginterferon alfa-2a and ribavirin combination therapy in patients with dual chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, 11.2% of patients achieved clearance of hepatitis B surface antigen (HBsAg) at 6 months after treatment; however, reactivation of HBV DNA was observed in 36.3%. We investigated the predictive potential of HBsAg quantification...

Journal: :Journal of virology 1995
R Schirmbeck W Böhm K Ando F V Chisari J Reimann

The efficiency of different vaccination techniques to prime in vivo major histocompatibility complex class I-restricted murine cytotoxic T-lymphocyte (CTL) precursors to hepatitis B virus small surface antigen (HBsAg) was investigated. Mice were immunized either by injection of a low dose of recombinant HBsAg protein preparations (native HBsAg particles or denatured HBsAg monomers) without adju...

Journal: :Frontiers in Public Health 2021

Background: Hepatitis B surface antigen (HBsAg) and viral load are important clinical indicators for antiviral therapy. Few studies have evaluated sequence biomarkers predicting the risk of hepatocellular carcinoma (HCC) in stage, which show a low serological response (HBsAg < 100 IU/ml) high levels (HBV DNA > 2,000 IU/ml). This study aims to determine trend biological prevalence ...

2018
Peng Hu Jia Shang Wenhong Zhang Guozhong Gong Yongguo Li Xinyue Chen Jianning Jiang Qing Xie Xiaoguang Dou Yongtao Sun Yufang Li Yingxia Liu Guozhen Liu Dewen Mao Xiaoling Chi Hong Tang Xiaoou Li Yao Xie Xiaoping Chen Jiaji Jiang Ping Zhao Jinlin Hou Zhiliang Gao Huimin Fan Jiguang Ding Dazhi Zhang Hong Ren

Background and Aims: Hepatitis B surface antigen (HBsAg) loss is seldom achieved with nucleos(t)ide analog (NA) therapy in chronic hepatitis B patients but may be enhanced by switching to finite pegylated-interferon (Peg-IFN) alfa-2a. We assessed HBsAg loss with 48- and 96-week Peg-IFN alfa-2a in chronic hepatitis B patients with partial response to a previous NA. Methods: Hepatitis B e antigen...

2006
V V Ionasescu

Sir, I read with interest the paper by Mollica et al.1 and should like to add the results of our prospective study for comparison with other Mediterranean countries on 37 HBsAg mothers who were found among 1002 pregnant women attending a maternity hospital. Although 3.7% of the mothers were positive for HBsAg, only in 0. 1 % of cord blood specimens was HBsAg demonstrable by counter electrophore...

2010
H Scheiblauer M El-Nageh S Diaz S Nick H Zeichhardt H-P Grunert A Prince

BACKGROUND AND OBJECTIVES This study was conducted by the International Consortium for Blood Safety (ICBS) to identify high-quality test kits for detection of hepatitis B virus (HBV) surface antigen (HBsAg) for the benefit of developing countries. MATERIALS AND METHODS The 70 HBsAg test kits from around the world were evaluated comparatively for their clinical sensitivity, analytical sensitiv...

2011
Ming-Lun Yeh Chao-Hung Hung Jee-Fu Huang Chun-Jen Liu Chuan-Mo Lee Chia-Yen Dai Jing-Houng Wang Zu-Yau Lin Sheng-Nan Lu Tsung-Hui Hu Ming-Lung Yu Jia-Horng Kao Wan-Long Chuang Pei-Jer Chen Ding-Shinn Chen

BACKGROUND Interferon-α/ribavirin combination therapy might promote hepatitis B surface antigen (HBsAg) seroclearance in patients dually infected with hepatitis B and C viruses (HBV/HCV), but the long-term effect remains unclear. We aimed to investigate the rate of and the factors associated with HBsAg seroclearance during long-term follow-up after interferon-α/ribavirin combination therapy in ...

Journal: :Annals of hepatology 2014
Pin-Nan Cheng Yen-Cheng Chiu Hung-Wen Tsai Ru-Hsueh Wang Hung-Chih Chiu I-Chin Wu Ting-Tsung Chang

INTRODUCTION The intrahepatic hepatitis B surface antigens (HBsAg) expression is related to disease progression of chronic hepatitis B. We examined the features of intrahepatic HBsAg expression. MATERIAL AND METHODS A total of 181 patients with e antigen positive chronic hepatitis B were enrolled. Patterns and semi-quantitative measurement of intrahepatic HBsAg expression were analyzed. The a...

Journal: :Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2015
Marie Pancher Nathalie Désiré Yen Ngo Sepideh Akhavan Coralie Pallier Thierry Poynard Vincent Thibault

BACKGROUND Presence at the same time of HBsAg and anti-HBs antibodies (HBsAg/Ab) is an entity sometimes encountered in chronic hepatitis B (CHB) carriers. OBJECTIVES This study was designed to characterize such serological profiles and to assess the reliability of serological marker quantification by three commercially available assays in this setting. STUDY DESIGN Among 2578 CHB identified...

Journal: :Stroke 2007
Joohon Sung Yun-Mi Song Yoon-Ho Choi Shah Ebrahim George Davey Smith

BACKGROUND AND PURPOSE Conflicting findings on the possible association between hepatitis B virus surface antigen (HBsAg) seropositivity and atherosclerosis have been reported. We examined the association between HBsAg seropositivity and cardiovascular diseases in a cohort of Koreans with a high prevalence of hepatitis B viral infection. METHODS Men (N=521 421) aged 30 to 64 years were catego...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید